DanielHollanderMD

PubMed

• DDS Profile: Daniel Hollander, MD.
  Daniel Hollander
  Digestive Diseases and Sciences. 2022-09-01
• 1 citations
  DDS Perspective: Crohn's Disease and Increased Intestinal Permeability-Initial Demonstration and Birth Pains.
  Daniel Hollander
  Digestive Diseases and Sciences. 2022-09-01
• 84 citations
  The “Leaky Gut”: Tight Junctions but Loose Associations?
  Daniel Hollander, Jonathan D. Kaunitz
  Digestive Diseases and Sciences. 2020-05-01

Journal Articles

• Intestinal permeability barrier in Crohn's disease: The difficulty in shifting the paradigm.  
  Hollander D, Digestive Diseases and Sciences, 1/1/2013
• Comparison of prostaglandin and Cimetidine in protection of isolated gastric glands against indomethacin injury.  
  Brzozowski T, Tarnawski A, Hollander D, Sekhon S, Krause WJ, Gergely H, J. of Physiology and Pharmacology, 1/1/2005
• Is artificial intelligence an intelligent choice for gastroenterologists?  
  Hollander D, Digestive and Liver Diseases, 1/1/2003
• Inflammatory Bowel Diseases and Brain-Gut Axis.  
  Hollander D, Journal of Physiology and Pharmacology, 1/1/2003
• Crohn's Disease TNF Alpha and the Leaky Gut. The Chicken or the Egg?  
  Hollander D, American J of Gastroenterology, 1/1/2002
• Intestinal permeability in patients with Crohn's disease and their relatives.  
  Hollander D, Digestive and Liver Diseases, 1/1/2001
• Clinician's guide through the tight junctions.  
  Hollander D, Italian J of Gastroenterology and Hepatology, 1/1/1999
• Intestinal permeability, leaky gut, and intestinal disorders.  
  Hollander D, Current Gastroenterology Reports, 1/1/1999
• American Gastroenterology at the end of the millennium and beyond.  
  Hollander D, Italian J of Gastroenterology and Hepatology, 1/1/1998
• Applications of the MTT assay to functional studies of mouse intestinal intraepithelial lymphocytes.  
  Ni J and Hollander D, Journal of Clinical Laboratory Analysis, 1/1/1996
• Immunological abnormality in C3H/HeJ mice with heritable inflammatory bowel disease.  
  Ni J, Chen SF and Hollander D, Cellular Immunology, 1/1/1996
• Effect of dextran sulfate sodium on the intestinal epithelial cells and intestinal lymphocytes.  
  Ni J, Chen SF and Hollander D, Gut, 1/1/1996
• Effects of experimental hemosiderosis on intestinal morphology, permeability, and tissue iron content.  
  Meshkinpour H, Vaziri ND, Zhou XJ, Erickson R, Liao SY, Oveisi F, Bemanian S, and Hollander D, Digestive Diseases and Sciences, 1/1/1996
• Mechanism of colonic permeation of inulin: is rat colon more permeable than small intestine?  
  Ma TY, Hollander D, Erickson RA, Truong H, Nguyen H and Krugliak P, Gastroenterology, 1/1/1995
• NSAID-induced gastroduodenal damage - prevention and treatment--Foreward.  
  Hollander D, Digestive Diseases, 1/1/1995
• Intestinal permeability: an overview.  
  Bjarnason I, MacPherson A and Hollander D, Gastroenterology, 1/1/1995
• Beta7 integrins and other cell adhesion molecules are differentially expressed and modulated by TNFb in different lymphocyte populations.  
  Ni J, Porter AG and Hollander D, Cell-Immunology, 1/1/1995
• Expression of Beta7 integrins and other cell adhesion molecules on mouse lymphocytes and their modulation by a new cytokine, IL-2 receptor-inducing factor.  
  Ni J and Hollander D, Cell-Immunology, 1/1/1995
• Adhesion molecule expression and adhesion properties of murine intestinal intraepithelial lymphocyte hybridomas.  
  Ni J, Hollander D, Sydora B and Panwala C, Cell-Immunology, 1/1/1995
• Cytoskeletal regulation of CACO-2 intestinal monolayer paracellular permeability.  
  Ma TY, Hollander D, Tran LT, Nguyen D, Hoa N and Bhalla D, J Cell Physiology, 1/1/1995
• Medical education for the year 2000 and beyond.  
  Hollander, D, Kansas Medicine, 7/1/1994
• Effects of total parenteral nutrition on intestinal morphology and function in humans.  
  Buchman AL, Moukarzel AA, Ament ME, Eckhert C, Bhuta S, Mestecky J and Hollander D, Transplant-Proc, 6/1/1994
• Intestinal permeability in patients with Crohn's disease and ulcerative colitis and their first degree relatives.  
  Munkholm P, Langholz E, Hollander D, Thornberg K, Orholm M, Katz KD and Binder V, Gut, 1/1/1994
• Gastrointestinal complications of nonsteroidal anti-inflammatory drugs: prophylactic and therapeutic strategies.  
  Hollander D, The American Journal of Medicine, 1/1/1994
• Mechanisms and sites of mannitol permeability of small and large intestine in the rat.  
  Krugliak P, Hollander D, Schlaepfer CC, Nguyen H and Ma TY, Digestive Diseases and Sciences, 1/1/1994
• Join now to see all

Books/Book Chapters

• Inflammatory Bowel Disease. 
  Chapter: Intestinal permeability in health and disease. 
  Page 45 - 54Hollander DEditors: Kirsner JB.WB Saunders Co., Philadelphia, PA1999
• Inflammatory Bowel Diseases - From Bench to Bedside. 
  Chapter: Are adhesion molecules important in inflammatory bowel disease? 
  Page 193 - 206Hollander DEditors: Andus T, Goebell H and Scholmerich J.Kluwer Academic Publishers, London, Great Britain1997
• Inflammatory Bowel Diseases. 
  Chapter: The role of adhesion molecules in IBD - emphasis on integrins. 
  Page 52 - 61Hollander DEditors: GNJ Tytgat, JFWM Bartelsman and SJH Van Deventer.Kluwer Academic Publishers, London, Great Britain1995
• Sucralfate - From Basic Science to the Bedside. 
  Chapter: Future research into the mechanisms of action of sucralfate. 
  Page 333 - 337Hollander DEditors: GNJ Tytgat.Plenum Publishers, New York1995
• Falk Symposium 72 - Inflammatory Bowel Diseases-1994. 
  Chapter: The importance of intestinal permeability in the pathogenesis of Crohn's disease. 
  Page 41 - 51Hollander DEditors: D Rachmilewitz.Kluwer Academic Publishers, Dordrecht/Boston/London1994
• Handbook of Experimental Pharmacology of Peptic Ulcer Disease. 
  Chapter: The role of essential fatty acids in gastric and duodenal protection and ulcer therapy. 
  Page 89 - 105Hollander D and Tarnawski AEditors: SB Benjamin and MJ Collen.Springer Verlag Publishers, Berlin1991
• Life span extension consequences and questions. 
  Chapter: Life span extension by means other than control of disease. 
  Page 43 - 54Cesario TC and Hollander DEditors: Frederic C Ludwig.Springer Publishing, New York1991
• Mechanisms of Peptic Ulcer Healing. 
  Chapter: The role of dietary essential fatty acids and fish oils in gastroduodenal mucosal protection against injury. 
  Hollander D and Tarnawski AEditors: F Halter, A Garner and GNJ Tytgat.Kluwer Academic Publishers, Dordrecht/Boston/London1991
• Mechanisms of Peptic Ulcer Healing. 
  Chapter: Role of angiogenesis in healing of experimental gastric ulcer. 
  Tarnawski A, Hollander D, Stachura J, Gergely H, Krause WJ and Sarfeh UEditors: F Halter, A Garner and GNJ Tytgat.Kluwer Academic Publishers, Dordrecht/Boston/London1990
• Current Therapy in Obstetrics and Gynecology. 
  Chapter: Gastrointestinal problems in pregnancy. 
  Hollander DEditors: EJ Quilligan and FP Zuspan.WB Saunders Publishers, Philadelphia, PA1990
• Gastroenterology International (3). 
  Chapter: Changing strategies for chronic peptic ulcer disease. 
  Page 3 - 21Bardhan KD, Hollander D, Feston K and Bianchi Porro GInternational University Press1990
• Treatment of Digestive Disease With Sucralfate. 
  Chapter: Mechanisms of protective and therapeutic actions of sucralfate. 
  Hollander D and Tarnawski AEditors: G Bianchi Porro and D Hollander.Raven Press, New York1989
• Gastric Cytoprotection - A Clinician's Guide. 
  Chapter: The role of nutrient essential fatty acids in gastric mucosal protection. 
  Hollander D and Tarnawski APlenum Publishing, New York1989
• Bailliere - Clinical Rheumatology. 
  Chapter: Intestinal mucosal permeability and rheumatologic diseases. 
  Page 271 - 284Katz KD and Hollander DEditors: Bailliere.WB Saunders, London, Great Britain1989
• Gastric Protection. 
  Chapter: Sucralfate - a topical cytoprotective agent: Mechanisms of protective, therapeutic and prophylactic actions. 
  Tarnawski A, Hollander D and Gergely HEditors: Rodolfo Cheli.Raven Press, New York1988
• Aging In Liver and Gastrointestinal Tract. 
  Chapter: Influence of aging on dietary lipid absorption by the small intestine. 
  Hollander DEditors: L Bianchi, P Holt, DFW James and RN Butler.MTP Press, Lancaster, UK1988
• New Pharmacology of Ulcer Disease. Experimental and New Therapeutic Approaches. 
  Chapter: Protective effect of sucralfate on the gastric mucosa mediated by endogenous prostaglandins. 
  Page 404 - 412Hollander D and Tarnawski AEditors: S Szabo and G Mozsik.Elsevier Publishers, New York1987
• New Pharmacology of Ulcer Disease. Experimental and New Therapeutic Approaches. 
  Chapter: Arachidonic acid protection of the gastric mucosa against ethanol injury. 
  Page 338 - 351Tarnawski A and Hollander DEditors: S Szabo and G Mozsik.Elsevier Publishers, New York1987
• Annual Review of Medicine Vol 37. 
  Chapter: Gastric mucosal injury. 
  Page 107 - 125Holt K and Hollander DEditors: WP Creger.1986
• Current Gastroenterology Vol 5. 
  Chapter: The small intestine. 
  Page 69 - 102Hollander DEditors: G Gitnick.Yearbook Medical Publishers, Inc., Chicago1985
• Gastroenterology Annual III 
  Chapter: Nutrition, selected issues. 
  Glick ME and Hollander DEditors: F Kern and AL Blum.Elsevier Science Publishing Co., New York1985
• Bockus Gastroenterology. 
  Chapter: Complications of peptic ulcer disease. 
  Page 1155 - 1185Pelot D and Hollander DEditors: Berk J. E., Haubrich W. S., Kaber M. H., Schaffner F..WB Saunders, Philadelphia, PAEdition 4th ,1985
• Current Therapy in Internal Medicine. 
  Chapter: Duodenal ulcer. 
  Page 577 - 583Hollander DEditors: TM Bayless.BC Decker, Inc., Philadelphia, PA1984
• Current Therapy in Gastroenterology and Liver Disease. 
  Chapter: Duodenal Ulcer. 
  Page 53 - 59Hollander DEditors: TM Bayless.BC Decker, Inc., Philadelphia, PA1984
• Current Gastroenterology. 
  Chapter: Small intestinal disorders. 
  Page 73 - 90Hollander DEditors: G Gitnick.J. Wiley and Sons, New York1983
• Join now to see all

Abstracts/Posters

• Cytoskeletal regulation of caco-2 intestinal monolayer paracellular permeability.
  Ma TY, Hollander D, Nguyen D and Hoa N, Gastroenterology, 1/1/1995
• Intestinal permeability is not increased in HIV+ patients.
  Weinshel EH, Skiar BF, Raicht RF, Ma TY and Hollander D, Gastroenterology, 1/1/1994
• Small intestinal transport route of permeability probes mannitol and PEG 400.
  Ma T, Hollander D, Roga R and Bhalla D, Gastroenterology, 1/1/1992
• Mechanisms of colonic permeation of inulin.
  Hollander D, Erickson R, Truong H, Nguyen H and Kruglaik P, Gastroenterology, 1/1/1992
• Basic mechanisms of mannitol permeability of perfused rat intestine.
  Krugliak P, Hollander D and Ma T, Gastroenterology, 1/1/1992
• Mechanism of anti-oxidant protection against oxygen radical injury of cultured small intestinal epithelial monolayers.
  Ma TY, Hollander D, Nguyen T and Nguyen H, Gastroenterology, 1/1/1991
• Effect of aging and life-prolonging calorie-restricted diet on intestinal permeability.
  Ma TY, Hollander D, Dadufalza V and Krugliak P, Gastroenterology, 1/1/1991
• Alternations in intestinal permeability during prolonged high intensity running.
  Moses F, Singh A, Smoak B, Hollander D and Deuster P, Gastroenterology, 1/1/1991
• Simplifying PEG 400 permeability studies - influence of feeding vs fasting or diurnal variation on PEG 400 permeability.
  Winkle P, Katz K, Hollander D, Dadufalza V, Dang L, Ghanavati S, Nguyen K, Nguyen L, Ma T and Krugliak P, Gastroenterology, 1/1/1991
• The critical role of calcium in ethanol injury of isolated human gastric gland cells.
  Tarnawski A, Durbin T, Brozowski T, Sarfeh U, Krause WJ and Hollander D, Gastroenterology, 1/1/1990
• Angiogenic response of damaged gastric mucosa - A prostaglandin mediated process?
  Tarnawski A, Hollander D, Stachura J, Cheffield M, Gergely H and Krause WJ, Gastroenterology, 1/1/1990
• Oxygen free radical injury of small intestinal epithelial monolayers.
  Ma TY, Hollander D and Krugliak P, Gastroenterology, 1/1/1990
• Intestinal IEG-18 as an in-vitro permeability model of crypt epithelia.
  Ma TY, Hollander D, Krugliak P and Nguyen H, Gastroenterology, 1/1/1990
• Angiogenic response of gastric mucosa to ethanol injury is abolished by indomethacin.
  Tarnawski A, Hollander D, Stachura J, Sarfeh U, Gergely H and Krause WJ, Gastroenterology, 1/1/1989
• Analysis of relative urinary recovery of individual molecular weight fractions of polyethylene glycol 400 after oral and intravenous administration.
  Ma TY, Hollander D, Krugliak P and Katz KD, Gastroenterology, 1/1/1989
• Mechanisms of polyethylene glycol 400 colonic absorption.
  Krugliak P, Hollander D, Schlaepter CC, Katz KD, Dadufalza VD and Ma TY, Gastroenterology, 1/1/1989
• Effect of prostanoids on polyethylene glycol 400 intestinal permeability.
  Krugliak P, Hollander D, Le Y, Katz KD, Dadufalza VD and Ma TY, Gastroenterology, 1/1/1989
• Development, evolution and healing of experimental gastric ulcer time sequence of histologic and ultrastructural changes.
  Tarnawski A, Stachura J, Hollander D, Dabros W, Eltorai M, Piastucki I and Bui HX, Gastroenterology, 1/1/1988
• Essential fatty acids-arachidonic and linoleic-exert trophic and angiogenic effects on the gastric mucosa injured by alcohol.
  Tarnawski A, Hollander D, Stachura J, Krause WJ and Gergely H, Gastroenterology, 1/1/1988
• Intestinal transport mechanisms of a clinically useful permeability probe-PEG 400.
  Krugliak P, Hollander D, Tran D, Dadufalza VD and Katz KD, Gastroenterology, 1/1/1988
• Delineation of the range of intestinal permeability abnormalities in patients with Crohn's disease and their healthy relatives.
  Katz KD, Hollander D, McElae C, Delahunty T, Dadufalza VD, Krugliak P, Vadheim CM and Rotter JI, Gastroenterology, 1/1/1988
• Influx of extracellular calcium - A key factor in ethanol injury of isolated gastric gland cells.
  Tarnawski A, Piastucki I, Hollander D, Krause WJ and Gergely H, Gastroenterology, 1/1/1987
• Indomethacin injury of isolated gastric gland cells is dependent on extracellular calcium.
  Tarnawski A, Hollander D, Gergely H and Stachura J, Clin Res, 1/1/1987
• Intestinal malabsorption of linoleic acid (LA) in experimental uremia.
  Barbari A, Vaziri ND and Hollander D, Clin Res, 1/1/1987
• Penetration of intestinal "Barrier" by polyethylene glycol 900-mechanism and route of transport.
  Hollander D, Koyama S, Dadufalza V and Ling KY, Gastroenterology, 1/1/1987
• Join now to see all

Lectures

• Conference Co-chair and speaker - Advances in Inflammatory Bowel Diseases, Center for Health Sciences, University of California 
  Los Angeles, CA - 10/28/2011
• Conference Co-Chair - Recent advances in Inflammatory Bowel Diseases, Center for Health Sciences, University of California 
  Los Angeles, CA - 9/14/2009
• Invited Speaker - Advances in Inflammatory Bowel Disease, Experimental Therapy in IBD 
  University of California, Irvine Conference - 11/3/2007
• Invited Speaker - Medical Grand Rounds, New Etiological and Therapeutic thoughts in Inflammatory Bowel Diseases. 
  The University of Alberta, Edmonton, Alberta - 10/6/2006
• Invited Speaker - The Brain-Gut Axis Symposium 
  Jagellonian University and the Polish Academy of Sciences and Arts, Krakow, Poland - 11/14/2003
• Invited Speaker - Digestive Disease Week - Clinical Implications of Changes in Intestinal Functions with Development and Aging, Research Symposium. 
  Orlando, FL - 5/20/2003
• Visiting Professor and Grand Rounds Speaker - Etiology, pathogenesis and new therapeutic approaches to IBD. 
  University of New Mexico, Albuquerque, NM - 4/24/2003
• Keynote Speaker - Association of Independent Research Institutes - Biomedical Research 2000 and Beyond. 
  Santa Monica, CA - 10/4/2000
• Medical Grand Rounds Speaker - Advances in IBD Therapy, St. Mary's Medical Center 
  San Francisco, CA - 4/14/1998
• Visiting Professor and Medical Grand Rounds Speaker - The University of California at Davis - The Role of Intestinal Permeability in the Etiology and Management of Cro... 
  Davis, Ca - 11/12/1997
• Intestinal Permeability Changes in Crohn's Disease Patients and Their Relatives Mechanisms and Potential Therapeutic Approaches, Invited Speaker 
  Xoma Corporation, Berkeley, CA - 10/28/1997
• Invited Speaker, Dean's Executive Group, School of Medicine, Stanford University. "Reorganization of the Veterans Administration - Implications to Academic Medicine". 
  Palo Alto, CA - 3/7/1997
• External Reviewer, Department of Medicine, The University of Maryland School of Medicine 
  Baltimore, MD - 11/21/1996
• Invited Speaker, International Falk Symposium on Inflammatory Bowel Disease - "The Role of Adhesion Molecules in Inflammatory Bowel Disease" 
  Freiburg, West Germany - 10/26/1996
• Visiting Professor and External Doctoral Thesis Examiner, The Department of Medicine and Department of Graduate Studies, The University of Calgary 
  Calgary, Canada - 6/6/1996
• Invited Speaker, San Diego Gastroenterological Association 
  San Diego, CA - 1/23/1996
• Invited Speaker, Association of American Medical Colleges - "Team Approach to Medical Care" 
  Washington, DC - 10/29/1995
• Organizing Committee and Invited Speaker, International Symposium on Inflammatory Bowel Diseases 
  Den Haag, Netherlands - 6/29/1995
• Invited Speaker, IV International Symposium on Inflammatory Bowel Diseases 
  Strasbourg, France - 9/6/1993
• Invited Speaker, Clinical Therapeutics of IBD - Present and Future, "The Role of Permeability in Inflammatory Bowel Disease", Organized by the University of Chicago 
  Tucson, AZ - 11/13/1992
• State-of-the-Art Lecture, "NSAIDS and the GI Tract" First United European Gastroenterology Week 
  Athens, Greece - 9/25/1992
• Visiting Professor and Grand Rounds Speaker, Department of Medicine, University of California-San Diego 
  San Diego, CA - 4/28/1992
• Invited Speaker, Inflammatory Bowel Disease, Falk Symposium 
  Titisee, Germany - 10/6/1991
• Invited Speaker, International Symposium on Protection, Repair and Healing of Gastro duodenal Mucosa 
  Kauai, HI - 11/8/1990
• Invited Speaker, Mucosal Protection, Falk Symposium 
  Freiburg, West Germany - 10/8/1990
• Join now to see all